Teva Pharmaceutical Industries (NYSE:TEVA) just landed U.S. FDA approval for UZEDY, an extended-release injectable developed with Medincell, for adults living with bipolar I disorder. This move ...

Teva Pharmaceutical Industries Limited is regaining investor interest as restructuring efforts drive margin improvements and unlock pipeline potential. Turnaround: company is changing to a more ...

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs. White House spokesman Kush Desai told the Wall Street Journal that "the administration is not actively ...

PARSIPPANY, N.J. - The U.S. Food and Drug Administration has approved UZEDY (risperidone) extended-release injectable suspension for the maintenance treatment of bipolar I disorder in adults, Teva ...

The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone. Along ...

The management of Israeli pharma group Teva has laid out its strategy for a return to growth after a challenging few years, with a greater emphasis on innovative medicines and a focus on complex, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International ...

Over the past year, Druckenmiller's family office fund has jettisoned its stake in Nvidia and Palantir. While Druckenmiller is clearly bullish on artificial intelligence, he is also wary of high ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks under $100. On October 9, BofA raised the firm’s price target on Teva to $24 from $22, while keeping a Buy rating ...

Representative Mikie Sherrill, a New Jersey Democrat, said a firm once owned by her Republican opponent, Jack Ciattarelli, spread misinformation about opioids. His campaign has threatened to sue her ...